Prelude Therapeutics Incorporated (PRLD) is listed on U.S. exchanges, last quoted at $3.05 with a $169.97M market capitalization. AI MoonshotScore: 72/100 (Buy). AI signals are mostly positive.

For informational purposes only. Not financial advice.